Cellular redox signalling is mediated by the post-translational modification of proteins in signal-transduction pathways by ROS/RNS (reactive oxygen species/reactive nitrogen species) or the products derived from their reactions. NO is perhaps the best understood in this regard with two important modifications of proteins known to induce conformational changes leading to modulation of function. The first is the addition of NO to haem groups as shown for soluble guanylate cyclase and the newly discovered NO/ cytochrome c oxidase signalling pathway in mitochondria. The second mechanism is through the modification of thiols by NO to form an S-nitrosated species. Other ROS/RNS can also modify signalling proteins although the mechanisms are not as clearly defined. For example, electrophilic lipids, formed as the reaction products of oxidation reactions, orchestrate adaptive responses in the vasculature by reacting with nucleophilic cysteine residues. In modifying signalling proteins ROS/RNS appear to change the overall activity of signalling pathways in a process that we have termed 'redox tone'. In this review, we discuss these different mechanisms of redox cell signalling, and give specific examples of ROS/RNS participation in signal transduction.
Introduction
The mechanisms through which cells co-ordinate responses to environmental stimuli form the basis of the now extensive field of signal transduction.
The initial development of this discipline resulted in the evolution of a straightforward paradigm in which a signal is detected by a receptor, which couples the binding of the messenger to the enzymic formation of a second messenger that in turn activates other protein cascades. The activation of such a pathway and the resultant cross-talk with other signal-transduction systems then results in a modified cellular response. This simple model evolved to define several benchmarks for characterizing a signalling pathway at the molecular level. It is now broadly accepted that signal-transduction pathways should show specificity in distinguishing the primary signal from other structurally similar stimuli, are localized within signalling domains, are controlled by a number of reversible steps and amplify the primary signal. Initially, specificity was largely thought to be inherent in the structural complexity of the signalling molecule and a well-defined 'glove-like' fit to a receptor protein. However, with the realization that NO can act as a signalling molecule, many of the concepts thought to be cornerstones of the signal-transduction field have had to be revised [1] [2] [3] .
These changes have resulted in a new sub-field of biology, loosely termed 'redox cell signalling' [4] [5] [6] . It is now widely accepted that changes in the reductive or oxidative capacity of the cell play an important regulatory role in cell differentiation and apoptosis. Loss of control of these signalling pathways is thought to contribute to the pathogenesis of chronic diseases such as atherosclerosis, cancer, diabetes and neurodegeneration [7] [8] [9] [10] [11] . In this model, cell dysfunction induced by ROS/RNS (reactive oxygen species/reactive nitrogen species) is subtle and can occur at a relatively low level of modification of biomolecules and is akin to the collapse of cell communication through corruption of the basic control systems.
An experimental difficulty encountered in testing these ideas has been to distinguish non-specific damage to biomolecules by ROS/RNS from specific perturbations in cell-signalling pathways. Indeed in the free radical field a competing view is enshrined in the concept of 'oxidative' or more recently 'nitrative', or 'nitrosative', stress [12, 13] . This model is distinct from the one outlined above in that non-specific modification of biomolecules by ROS/RNS exceeds the capacity of antioxidant systems to either prevent or repair this damage, leading to the equivalent of 'urban' decay and demise of the cell. In this paradigm the collapse of the cellular infrastructure is the basis of cell dysfunction. To some extent the low level and chronic accumulation of oxidative damage in signalling pathways and the oxidative stress models are not mutually exclusive and it is at the interface between these two currently competing ideas that much of the new and interesting research is being conducted. This short overview explores some of these concepts and describes some of the molecular mechanisms that lead to redox-dependent cell signalling.
Formation and reactions of ROS/RNS
The primary reactive oxygen and nitrogen species formed in biological systems are NO, O 2 • Ϫ (superoxide radical) and H 2 O 2 ( Figure 1 ). It is important to note that formation of each of these primary species can be controlled under biological conditions. Three isoforms of the enzyme NOS (nitric oxide synthase) have been identified in mammalian systems, all of which utilize NADPH to catalyse the conversion of L-arginine to L-citrulline, generating NO [14] . The high-output form of the enzyme, inducible NOS, is regulated mainly at the level of protein expression, and is induced by stimuli such as cytokines, whereas the low-output forms of NOS, endothelial NOS and neuronal NOS, are regulated at both the level of expression and the level of catalytic activity [15] [16] [17] [18] . A number of kinases and phosphatases control endothelial NOS activation, while the association of the enzyme with caveolin, a regulatory protein, leads to its inactivation [19, 20] . Phosphorylation of the enzyme is regulated by several factors, including ischaemic stress, vascular endothelial growth factor and bradykinin, while transforming growth factor ␤ and oestrogen induce gene expression [21] [22] [23] [24] [25] . Interestingly, many stimuli, such as shear stress and H 2 O 2 , regulate both the activation and induction of endothelial NOS [26] [27] [28] [29] . Recently, evidence has been found for a mito- chondrial isoform of NOS [30] . Although relatively little is known about its regulation, its existence is intriguing in terms of signal transduction involving the mitochondrion, potentially through the generation of O 2 • Ϫ . There are several sources of O 2 • Ϫ in the cell. Mitochondria generate the radical through normal turnover of the electron-transport chain, and this will be discussed later [31] . Another physiological source of O 2
• Ϫ is the haemcontaining enzyme NADPH oxidase in inflammatory cells, which oxidizes NADPH to NADP ϩ , reducing O 2 to O 2
• Ϫ in the process [32] . Although this enzyme was initially identified in phagocytes, and found to be responsible for the production of ROS used to eliminate invading pathogens, NADPH oxidase isoforms are now recognized as a broad family of enzymes found in other cell types including endothelial cells and platelets [33] [34] [35] . The very existence of this large family of highly controlled proteins, many only capable of generating either O 2
• Ϫ or H 2 O 2 at very low rates, is a strong circumstantial argument for their role in cell signalling [36, 37] .
H 2 O 2 can be generated in the cell through the dismutation of O 2 • Ϫ by the enzyme SOD (superoxide dismutase). This enzyme exists in three forms: extracellular SOD, Cu/ZnSOD present in the cytosol, and the mitochondrial isoform, MnSOD. The previous concept in the free radical field was that a large proportion of the formation of O 2
• Ϫ and H 2 O 2 resulted from misdirected electron transfer and was deleterious to the cell [38] . A classic example of this concept is the formation of H 2 O 2 from mitochondria. However, it has recently become apparent that the production of O 2
• Ϫ from the mitochondria and its subsequent dismutation to H 2 O 2 is a tightly controlled process and plays an important role in redox cell signalling, as will be discussed in detail below.
The fate of these primary ROS/RNS is interesting with some evidence for both a direct interaction with a receptor (such as NO with guanylate cyclase) and transduction to other compounds capable of initiating signalling events. H 2 O 2 can directly oxidize protein thiols forming sulphenic acid, as well as mediating the formation of disulphide bonds [39] . The formation of a series of secondary reactive species occurs through the interactions of NO, O 2 • Ϫ or H 2 O 2 with each other, resulting in further modification of biomolecules ( Figure 1 ). Superoxide reacts rapidly with NO to form peroxynitrite (ONOO Ϫ ), which results in the nitration of aromatic protein residues, most notably tyrosine [40] . While nitrotyrosine has been detected in a range of pathological conditions, including atherosclerotic lesions, rheumatoid arthritis and Alzheimer's disease, currently no evidence supports (or refutes) the hypothesis that tyrosine nitration serves a signalling function [41] [42] [43] . Interestingly, it has been suggested that ONOO Ϫ may perform this role in ischaemic pre-conditioning and the response of the endothelium to blood flow [44] [45] [46] .
In addition to reacting with O 2 • Ϫ to form peroxynitrite, NO reacts with O 2 to form dinitrogen trioxide (N 2 O 3 ), a nitrosating agent resulting in S-nitrosothiol formation on the cysteine residues of proteins [47] . S-nitrosation, which is often called S-nitrosylation to acknowledge a potential role in signalling, has been shown to regulate several pathways, including the execution of apoptosis by caspases, the release of calcium by the ryanodine receptor and the regulation of the NMDA (N-methyl-D-aspartate) receptor [48] [49] [50] [51] [52] [53] .
In addition to the primary ROS/RNS, secondary reaction products interact with other biomolecules, such as unsaturated fatty acids, that can also play a role in redox signalling. This is not unexpected since enzymes such as cyclooxygenase and lipoxygenase catalyse the formation of the prostaglandins and leukotrienes [54] . These mediators of inflammation interact with classical Gprotein-coupled receptors on target cells to mediate a variety of responses [55, 56] . Of particular interest to the field of redox cell signalling is the relatively recent recognition that structurally analogous lipid mediators are formed nonenzymically. Thus the reaction of ROS/RNS with unsaturated fatty acids results in a spectrum of reaction products with quite different chemistry to the progenitor ROS/RNS. For example, lipid oxidation products are converted from oxidants to potent electrophiles, which have signalling capabilities independent of the classical receptor activation [57, 58] . This overlay of direct receptor-mediated responses and covalent modification of target proteins is also apparent in some of the products of the cyclo-oxygenase pathway. One well-studied example is the potent electrophilic lipid cyclopentenone prostaglandin, 15-deoxyprostaglandin J 2 . This molecule has been found in human atherosclerotic lesions and is both an agonist for the PPAR-␥ (peroxisome proliferator-activated receptor-␥), and has a number of biological actions independent of this receptor due to the covalent modification of proteins [59, 60] . Thus the primary mechanism for the PPAR␥-independent effects appears to lie in the chemical properties of these compounds. Electrophilic lipids are able to react directly with specific cysteine residues to form thiol adducts on target molecules, altering their function. For example, direct covalent modification of the protein keap-1 results in binding of nrf-2 and associated proteins with the ARE (antioxidant response element), leading to transcriptional regulation of enzymes such as haem oxygenase-1 or glutamyl cysteine ligase [60] [61] [62] . Such responses are not restricted to the J-series prostaglandins. For example, the isoprostanes, a unique group of prostaglandin-like lipids formed from the non-enzymic peroxidation of arachidonic acid, are able to mediate the activation of mitogen-activated protein kinases [57, 63, 64] . RNS are also known to react with fatty acids, yielding the production of nitrated lipids which may be formed in vivo [65] . Studies with synthesized nitrolinoleate have shown that it is able to inhibit platelet activation, relax pre-contracted aortic rings and inhibit neutrophil function [66] [67] [68] .
Mechanisms of control in redox cell signalling
Proteins that transduce an ROS/RNS signal must recognize distinct classes of molecule and be capable of coupling protein modification to a change in function. Since ROS/RNS can inactivate proteins, this presents a real dilemma in assigning a signalling role separate from a modification related to pathology. In some cases a gain in function is observed and a signalling role can then be confidently ascribed to the reaction in question. However, as will be discussed below, the balance between inhibition and activation of signalling molecules may be necessary for establishing a 'redox tone'. Ideally a conservative approach should be adopted in defining criteria to be satisfied before ascribing a cell-signalling function to a post-translational modification of proteins by ROS/RNS and should conform to the following general properties: (i) limited access of the ROS/RNS to the site for modification; (ii) responses should be initiated by biologically relevant concentrations of the ROS/RNS; (iii) reactivity of the target should be controlled by the surrounding amino acid sequence and transition metal content; and (iv) significant conformational change to the protein with gain or loss function by modification of specific amino acid residues should be observed.
However, at this early stage in this field of research not all of these criteria have been satisfied. The question of what is a biologically relevant concentration of ROS/RNS has also been a contentious issue. This has largely arisen because the concentrations of an oxidant such as H 2 O 2 required to activate a signal-transduction pathway when added to cells appears much higher than levels that could be achieved even under the most exuberant conditions for ROS formation. In many cases this is most likely to be due to the difficulty in modelling local intracellular formation and function for an autocrine signalling role for the molecule in question. For example, we have recently shown that much lower levels of H 2 O 2 are required to activate the mitogen-activated protein kinases when produced intracellularly than when added to the cell as a bolus [69] . Notwithstanding these limitations, Table 1 reports the ROS/RNS shown in Figure 1 and some of the signalling functions described in the literature that are likely to be mediated through post-translational modification of signalling proteins. 
Classification of redox signalling pathways
Redox signalling mechanisms can be divided into two broad categories. The first of these is exemplified by NO and is the classical receptor-mediated signalling in which the ROS/RNS bind to a specific protein target that generates the second messenger. The second category is more complex and occurs when ROS/RNS modulate the overall activity of a pathway by changing the number of signalling molecules that can be recruited to participate in a pathway activated by an ROS/RNS-independent agonist. An example in this category is the H 2 O 2 -dependent inactivation of phosphatases [70] . Since this mechanism establishes a threshold redox-dependent step for the action of other signalling molecules it is analogous to the concept of vascular tone familiar to the NO field. In this paradigm vascular function is controlled by the contrasting actions of vasodilators and vasoconstrictors, which by acting in opposition allow control of blood flow. Since the redox-dependent activation of inhibition of proteins can modulate the population of signalling molecules that can be recruited to signalling domains, these two opposing mechanisms control the overall activity of the signal-transduction pathway. We call this phenomenon 'redox tone' to distinguish it from direct receptor activation [71] . One example of the convergence of redox tone with classical receptor-mediated pathways is at the level of the mitochondrion.
Mitochondrial ROS/RNS formation and cell signalling
Physiologically, the majority of the electrons entering complex I and II enter the Q cycle and ultimately reduce cytochrome c. However, a fraction of the electrons are passed on to O 2 from ubisemiquinone, generating O 2
• Ϫ [31]. MnSOD present in the mitochondrial matrix then results in the formation of H 2 O 2 , which is able to diffuse out of the mitochondria to mediate signalling elsewhere (Figure 2 ) [72] . Recently the concept has emerged that H 2 O 2 formation from the organelle can be controlled, with the concentration of ROS produced being dependent on the reduction of the respiratory chain and modulated by NO [71, 73] . This allows generation of H 2 O 2 to be regulated by the availability of reducing equivalents entering the chain, and also by the presence of respiratory inhibitors, including xenobiotics such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine [74] [75] [76] . An important physiological regulator of respiration is NO, which acts through the inhibition of cytochrome c oxidase resulting in the reduction of complexes I-III, leading to an increase in O 2
• Ϫ and hence H 2 O 2 production [75,77]. As we have discussed previously this function requires that MnSOD can prevent the reaction of NO with O 2
• Ϫ to form peroxynitrite [71] . If this hypothesis is correct, loss of control of H 2 O 2 formation to mediate signal transduction consequent to the loss of MnSOD would be consistent with the lethality associated with deletion of this gene [78] . Furthermore, it has been suggested that nitration of MnSOD amplifies mitochondrial damage and has been shown to be associated with rejection of the transplanted kidney [79] .
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Complex I is another point in the respiratory chain at which mitochondrial ROS production can be regulated [76, 80] . It has recently been shown that specific subunits of complex I can be phosphorylated by protein kinase A and pyruvate dehydrogenase kinase, leading to a change in the activity of the enzyme [81] . On the other hand, incubation of mitochondria with pyruvate dehydrogenase kinase led to a decrease in complex I activity, which may potentially lead to increased O 2 • Ϫ production [81] . Although it is accepted that a fraction of the O 2 used by mitochondria ends up as H 2 O 2 , understanding of the role of mitochondrial ROS generation in cell signalling is still incomplete. However, several pathways have been shown to involve mitochondrially generated ROS, and some of these are listed in Table 2 . Mitochondrial ROS have been shown to mediate cytotoxic pathways in a variety of cell types [76, [82] [83] [84] . These species are involved in the execution of apoptosis by the Fas receptor and p53 [85, 86] . In addition, tumour necrosis factor ␣-induced death of tumour cells is mediated by the activation of NF-B (nuclear factor B) by mitochondrial ROS [82] , and is prevented by antioxidants and potentiated by increasing the generation of ROS from the respiratory chain [87] . Cardiomyocyte toxicity due to ischaemia has also been S. Shiva Opening of mitochondrial permeability T-cells [116] pore and cytochrome c release p53 Apoptosis HeLa cells [85] TNF-␣ Activation of NF-B Rat primary myoblasts [117] shown to involve mitochondrial ROS [84] . Interestingly, these species are also implicated in the protective effects of both ischaemic and acetylcholineinduced preconditioning [88] . The finding that mitochondrial ROS production increases in hypoxia [89] , and leads to the activation of p38 [90] and stabilization of hypoxia inducible factor 1␣ [91] , has led to a revival of the proposal that the mitochondrion acts as an 'oxygen sensor' in the cell [92, 93] . Mitochondrial ROS have also been implicated in several other adaptive responses, including the activation of p38 [94] , protein kinase C [95] and NF-B in response to high glucose [96, 97] , activation of c-Jun N-terminal kinase (JNK) to regulate glycogen synthesis [98] , and angiotensin II-induced activation of NF-B [99] . While mitochondrial ROS have been implicated in several signalling pathways, detailed molecular mechanisms are still unknown.
Summary
The classical model for signal transduction is the activation of a receptor by a specific molecule, which leads to the production of a second messenger and subsequent initiation of a cascade leading to a cellular change. This paradigm has since shifted to include a wide range of molecules as potential mediators of signal transduction, including ROS, RNS and lipid oxidation products. While pathways involving these species exhibit the characteristics of traditional signalling pathways, such as specificity and amplification, they are not all limited to activating a classical receptor. Instead, these species mediate post-translational modifications of specific target proteins, which in turn regulate the population of signalling molecules recruited to mediate a response. We have termed this concept redox tone.
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